No discernible effect of vitamin D supplementation on secondary outcomes in chronic spinal cord injury: Findings from a randomized controlled trial.

Context Sufficient vitamin D levels (serum 25(OH)D>75 nmol/L) have been associated with secondary health conditions and functional outcomes in individuals with chronic spinal cord injury (SCI). This study evaluated the effects of vitamin D3 supplementation on these outcomes. Design Randomized, placebo-controlled, double-blind clinical trial. Setting Specialized SCI center. Participants Participants included 42 individuals living with SCI for at least three years and exhibiting insufficient 25(OH)D levels at baseline (seven females, 35 males, mean age 48±10 years, 10 with tetraplegia, 32 with paraplegia). Interventions Participants were randomly assigned to receive placebo, medium-dose (24'000 IU every four weeks), or high-dose (24'000 IU every two weeks) vitamin D3 supplementation for 12 months. Outcome Measures For 12 months, the following parameters were evaluated at three-month intervals: 25(OH)D levels; occurrence of urinary tract infections, pressure injuries, falls, and pain; handgrip strength; functional independence; levels of fatigue, anxiety, and depression. Results Of the participants who received supplementation, 33% achieved sufficient 25(OH)D levels. Pain was reported by 79% of participants during the study, while falls (57%), urinary tract infections (55%), and pressure injuries (21%) were reported less frequently. Vitamin D3 supplementation demonstrated no measurable effect on any of the investigated parameters (all P-values ≥ 0.19). Conclusion Vitamin D3 supplementation resulted in sufficient 25(OH)D levels in only a minority of participants, which may account for the absence of effects on secondary outcomes relevant to SCI. Future studies should investigate the efficacy of higher supplementation doses, particularly for individuals with clinically relevant levels of the respective outcomes.Trial registration: The study was registered at ClinicalTrials.gov (registration ID: NCT04652544).

Publication Details

Journal
Open Access CRIS of the University of Bern
Published
2025-10-01
DOI
https://doi.org/10.48620/91718
Primary Topic
Genomics and Phylogenetic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

No discernible effect of vitamin D supplementation on secondary outcomes in chronic spinal cord injury: Findings from a randomized controlled trial.

Open Access CRIS of the University of Bern
Genomics and Phylogenetic Studies
article

No discernible effect of vitamin D supplementation on secondary outcomes in chronic spinal cord injury: Findings from a randomized controlled trial.

article en

Abstract

Context Sufficient vitamin D levels (serum 25(OH)D>75 nmol/L) have been associated with secondary health conditions and functional outcomes in individuals with chronic spinal cord injury (SCI). This study evaluated the effects of vitamin D3 supplementation on these outcomes. Design Randomized, placebo-controlled, double-blind clinical trial. Setting Specialized SCI center. Participants Participants included 42 individuals living with SCI for at least three years and exhibiting insufficient 25(OH)D levels at baseline (seven females, 35 males, mean age 48±10 years, 10 with tetraplegia, 32 with paraplegia). Interventions Participants were randomly assigned to receive placebo, medium-dose (24'000 IU every four weeks), or high-dose (24'000 IU every two weeks) vitamin D3 supplementation for 12 months. Outcome Measures For 12 months, the following parameters were evaluated at three-month intervals: 25(OH)D levels; occurrence of urinary tract infections, pressure injuries, falls, and pain; handgrip strength; functional independence; levels of fatigue, anxiety, and depression. Results Of the participants who received supplementation, 33% achieved sufficient 25(OH)D levels. Pain was reported by 79% of participants during the study, while falls (57%), urinary tract infections (55%), and pressure injuries (21%) were reported less frequently. Vitamin D3 supplementation demonstrated no measurable effect on any of the investigated parameters (all P-values ≥ 0.19). Conclusion Vitamin D3 supplementation resulted in sufficient 25(OH)D levels in only a minority of participants, which may account for the absence of effects on secondary outcomes relevant to SCI. Future studies should investigate the efficacy of higher supplementation doses, particularly for individuals with clinically relevant levels of the respective outcomes.Trial registration: The study was registered at ClinicalTrials.gov (registration ID: NCT04652544).

Open Access CRIS of the University of Bern
Good health and well-being
Openalex Percentile: Top 46%
Genomics and Phylogenetic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

No discernible effect of vitamin D supplementation on secondary outcomes in chronic spinal cord injury: Findings from a randomized controlled trial. · Open Access CRIS of the University of Bern (2025) | TGRS Research Map | TGRS